IL13RA2 and neoplasm: CAR-T cells, unlike other adoptive T cell products facilitate MHC-independent tumor cell killing by allowing T cells to bind target cell surface antigens, for instance IL-13Rα2 in the present study, through a single-chain variable fragment (scFv) recognition domain.